lobbying_activities: 2525135

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2525135	81179b60-d029-4797-b37c-4cb126921c6c	Q3	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2020	third_quarter	ANI	Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to counterfeit products - H.R. 4156 Issues related to rural broadband Issues related to foreign animal disease - H.R. 6921	Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE		610000	0	0	2020-10-20T10:25:47.390000-04:00